Skip to main content

Advertisement

SpringerLink
Log in

A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice

  • UNIVERSITY OF PITTSBURGH IMMUNOLOGY 2011
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Previous studies by our group, using an experimental autoimmune thyroiditis (EAT) model in Strain 13 inbred guinea pigs, resulted in T cell-mediated delayed hypersensitivity; however, autoantibodies proved not to be cytotoxic to thyroid epithelial cells in the presence or absence of complement proteins. Albeit, T cell-mediated lymphocyte cytotoxicity began to diminish sharply concomitantly with increasing titers of circulating autoantibodies, indicating a skewing of the self-reactive response and amelioration of the EAT. Furthermore, immunization of guinea pigs with thyroglobulin in incomplete Freund’s adjuvant (IFA) generated a high titer of antithyroglobulin antibodies and proved to inhibit thyroiditis. These observations indicated that the shift in the immune response from Th1 to Th2 and the production of antibodies were likely responsible for ameliorating EAT. Based upon these results, we extrapolated our studies to design a multivalent vaccine, which shows promise in preventing/reversing T1D in NOD mice. A small pilot study was conducted in which a total of 34 mice, 20 non-immunized controls and 14 immunized with syngeneic islet lysate, were monitored for mean day to diabetes for a total of 28 weeks. Immunization of NOD animals with syngeneic islet lysates resulted in a significant delay in diabetes onset (P < 0.001) as compared to non-immunized controls. To further assess the vaccine’s efficacy, robustness, and delay of disease, a large-scale experiment was conducted and monitored for 32 weeks using 106 mice, 64 non-immunized controls and 42 immunized with syngeneic islet lysate. At the end of the study, 90% of the non-immunized group developed diabetes, while less than 25% of the immunized group became diabetic (P < 0.0001). The protective effect, as a result of vaccination, correlated with an increase in the levels of IL-10 and IL-4 cytokines as well as a skewing to Th2-dependent isotype antibodies in serum. Strikingly, adoptive transfer of spleen cells from immunized animals into NOD.scid recipients provided protection against transfer of diabetes by diabetogenic spleen cells. The results of this study provide evidence that vaccination with islet lysate leads to a Th2-dependent skewing of the immune response to islet beta cells as a possible mechanism of protection. This strategy may be implemented as a possible vaccination protocol for arresting and/or preventing T1D in patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986;314:1360–8.

    Article  PubMed  CAS  Google Scholar 

  2. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–9.

    Article  PubMed  CAS  Google Scholar 

  3. Haller MJ, Gottlieb PA, Schatz DA. Type 1 diabetes intervention trials 2007: where are we and where are we going? Curr Opin Endocrinol Diabetes Obes. 2007;14:283–7.

    Article  PubMed  Google Scholar 

  4. Like AA, Dirodi V, Thomas S, Guberski DL, Rossini AA. Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A. Am J Pathol. 1984;117:92–7.

    PubMed  CAS  Google Scholar 

  5. Salama AD, Remuzzi G, Harmon WE, Sayegh MH. Challenges to achieving clinical transplantation tolerance. J Clin Invest. 2001;108:943–8.

    PubMed  CAS  Google Scholar 

  6. Stiller CR, Dupre J, Gent M, Jenner MR, Keown PA, Laupacis A, Martell R, Rodger NW, von Graffenried B, Wolfe BM. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 1984;223:1362–7.

    Article  PubMed  CAS  Google Scholar 

  7. Lin MS, Salvin SB. In vitro and in vivo studies on the mechanism of experimental autoimmune thyroiditis in guinea pigs. Cell Immunol. 1976;27:177–87.

    Article  PubMed  CAS  Google Scholar 

  8. Lin MS, Salvin SB. Further studies on the mechanism of experimental autoimmune thyroiditis in guinea pigs. Properties of thyroid cytotoxic factor (TCF) and its relationship to pathogenesis of the disease. Cell Immunol. 1976;27:188–99.

    Article  PubMed  CAS  Google Scholar 

  9. Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest. 1993;92:2313–22.

    Article  PubMed  CAS  Google Scholar 

  10. Peakman M, Wen L, McNab GL, Watkins PJ, Tan KC, Vergani D. T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens. Autoimmunity. 1994;17:31–9.

    Article  PubMed  CAS  Google Scholar 

  11. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 1993;341:1365–9.

    Article  PubMed  CAS  Google Scholar 

  12. Roep BO, Duinkerken G, Schreuder GM, Kolb H, de Vries RR, Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol. 1996;26:1285–9.

    Article  PubMed  CAS  Google Scholar 

  13. Bertera S, Crawford ML, Alexander AM, Papworth GD, Watkins SC, Robbins PD, Trucco M. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes. 2003;52:387–93.

    Article  PubMed  CAS  Google Scholar 

  14. Sklavos MM, Bertera S, Tse HM, Bottino R, He J, Beilke JN, Coulombe MG, Gill RG, Crapo JD, Trucco M, Piganelli JD. Redox modulation protects islets from transplant-related injury. Diabetes. 2010;59:1731–8.

    Article  PubMed  CAS  Google Scholar 

  15. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA. 2000;97:1701–6.

    Article  PubMed  CAS  Google Scholar 

  16. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes. 2002;51:347–55.

    Article  PubMed  CAS  Google Scholar 

  17. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011;91:79–118.

    Article  PubMed  Google Scholar 

  18. Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 1993;42:44–55.

    Article  PubMed  CAS  Google Scholar 

  19. Bergman B, Haskins K. Autoreactive T-cell clones from the nonobese diabetic mouse. Proc Soc Exp Biol Med. 1997;214:41–8.

    PubMed  CAS  Google Scholar 

  20. Cantor J, Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol. 2005;175:7738–45.

    PubMed  CAS  Google Scholar 

  21. Cantor J, Haskins K. Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1. J Immunol. 2007;179:5760–7.

    PubMed  CAS  Google Scholar 

  22. Haskins K, Wegmann D. Diabetogenic T-cell clones. Diabetes. 1996;45:1299–305.

    Article  PubMed  CAS  Google Scholar 

  23. Peterson JD, Berg R, Piganelli JD, Poulin M, Haskins K. Analysis of leukocytes recruited to the pancreas by diabetogenic T cell clones. Cell Immunol. 1998;189:92–8.

    Article  PubMed  CAS  Google Scholar 

  24. Sia C. Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus. Rev Diabet Stud. 2005;2:182–6.

    Article  PubMed  Google Scholar 

  25. Saunders KA, Raine T, Cooke A, Lawrence CE. Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun. 2007;75:397–407.

    Article  PubMed  CAS  Google Scholar 

  26. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes. 2007;56:2116–23.

    Article  PubMed  CAS  Google Scholar 

  27. Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, Noorchashm H. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med. 2002;8:399–402.

    Article  PubMed  CAS  Google Scholar 

  28. Forsgren S, Andersson A, Hillorn V, Soderstrom A, Holmberg D. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol. 1991;34:445–51.

    Article  PubMed  CAS  Google Scholar 

  29. Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes. 1997;46:941–6.

    Article  PubMed  CAS  Google Scholar 

  30. Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NOD.Ig mu null mice. J Exp Med. 1996;184:2049–53.

    Article  PubMed  CAS  Google Scholar 

  31. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol. 1998;161:3912–8.

    PubMed  CAS  Google Scholar 

  32. Silveira PA, Serreze DV, Grey ST. Invasion of the killer B’s in type 1 diabetes. Front Biosci. 2007;12:2183–93.

    Article  PubMed  CAS  Google Scholar 

  33. Kay TW, Campbell IL, Harrison LC. Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. J Autoimmun. 1991;4:263–76.

    Article  PubMed  CAS  Google Scholar 

  34. Kay TW, Chaplin HL, Parker JL, Stephens LA, Thomas HE. CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse. Res Immunol. 1997;148:320–7.

    Article  PubMed  CAS  Google Scholar 

  35. Thomas HE, Darwiche R, Corbett JA, Kay TW. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol. 1999;163:1562–9.

    PubMed  CAS  Google Scholar 

  36. Thomas HE, Kay TW. Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab Res Rev. 2000;16:251–61.

    Article  PubMed  CAS  Google Scholar 

  37. Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol. 2007;179:7225–32.

    PubMed  CAS  Google Scholar 

  38. Suarez-Pinzon WL, Rabinovitch A. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits. Int J Exp Diabetes Res. 2001;2:3–17.

    Article  PubMed  CAS  Google Scholar 

  39. Mangada J, Pearson T, Brehm MA, Wicker LS, Peterson LB, Shultz LD, Serreze DV, Rossini AA, Greiner DL. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice. Diabetes. 2009;58:165–73.

    Article  PubMed  CAS  Google Scholar 

  40. Pearson T, Weiser P, Markees TG, Serreze DV, Wicker LS, Peterson LB, Cumisky AM, Shultz LD, Mordes JP, Rossini AA, Greiner DL. Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3. Diabetes. 2004;53:1972–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to express their appreciation to Professor Dr. Philip Fireman for critical review of this manuscript.

Author information

Authors and Affiliations

  1. Immunogenetics/Pulmonary Medicine, Allergy and Immunology, Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, 15224, USA

    Ming S. Lin

  2. Immunogenetics, Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, 15224, USA

    Hubert M. Tse & Meghan M. Delmastro

  3. Immunogenetics/Immunology, Children’s Hospital of Pittsburgh and University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, 15224, USA

    Suzanne Bertera, Caterina T. Wong, Robert Lakomy, Jing He, Martha M. Sklavos, Gina M. Coudriet, Massimo Pietropaolo, Massimo M. Trucco & Jon D. Piganelli

Authors
  1. Ming S. Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hubert M. Tse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meghan M. Delmastro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suzanne Bertera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Caterina T. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert Lakomy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing He
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Martha M. Sklavos
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gina M. Coudriet
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Massimo Pietropaolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Massimo M. Trucco
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jon D. Piganelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jon D. Piganelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, M.S., Tse, H.M., Delmastro, M.M. et al. A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice. Immunol Res 50, 213–220 (2011). https://doi.org/10.1007/s12026-011-8215-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-011-8215-0

Keywords

Search

Navigation